BIOQUAL, Inc.
BIOQ
$56.00
-$1.50-2.61%
| Weiss Ratings | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.04 | |||
| Price History | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -6.67% | |||
| 30-Day Total Return | -6.67% | |||
| 60-Day Total Return | -13.85% | |||
| 90-Day Total Return | -16.42% | |||
| Year to Date Total Return | -13.85% | |||
| 1-Year Total Return | -29.48% | |||
| 2-Year Total Return | -30.62% | |||
| 3-Year Total Return | -35.96% | |||
| 5-Year Total Return | -5.62% | |||
| 52-Week High % Change | -27.27% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $77.00 | |||
| 52-Week Low Price | $56.00 | |||
| 52-Week Low Price (Date) | Apr 02, 2025 | |||
| 52-Week High Price (Date) | Apr 09, 2024 | |||
| Valuation | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 50.09M | |||
| Enterprise Value | 56.78M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.12 | |||
| Earnings Per Share Growth | 308.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.16 | |||
| Price/Book (Q) | 1.42 | |||
| Enterprise Value/Revenue (TTM) | 2.45 | |||
| Price | $56.00 | |||
| Enterprise Value/EBITDA (TTM) | -32.62 | |||
| Enterprise Value/EBIT | -19.24 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 894.40K | |||
| Dividend Yield | 0.89% | |||
| Div. Per Share (Most Recent) | $0.50 | |||
| Dividend Per Share (TTM) | $0.50 | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.50 | |||
| Company Info | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 240 404 7654 | |||
| Address | 9600 Medical Center Drive Rockville, MD 20850-3336 | |||
| Website | www.bioqual.com | |||
| Country | United States | |||
| Year Founded | 1981 | |||
| Profitability | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $25.90 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -28.19% | |||
| Earnings Growth (Q YOY) | -350.09% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -351.85% | |||
| Balance Sheet | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.46M | |||
| Cash Per Share (Q) | $12.82 | |||
| Total Current Assets (Q) | 30.08M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 35.32M | |||
| Current Ratio (Q) | 3.735 | |||
| Book Value Per Share (Q) | $39.48 | |||
| Total Assets (Q) | 58.15M | |||
| Total Current Liabilities (Q) | 8.05M | |||
| Total Debt (Q) | 18.16M | |||
| Total Liabilities (Q) | 22.83M | |||
| Total Common Equity (Q) | 35.32M | |||
| Cash Flow | BIOQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
